Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Pharm. Juris Hmelnickis
|
| gptkbp:country |
gptkb:Latvia
|
| gptkbp:founded |
1946
|
| gptkbp:headquarters_location |
gptkb:Riga
|
| https://www.w3.org/2000/01/rdf-schema#label |
Grindeks
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Ftorafur
Furaginum Mildronate |
| gptkbp:numberOfEmployees |
over 1000
|
| gptkbp:parentCompany |
Liplat Holding
|
| gptkbp:products |
active pharmaceutical ingredients
finished dosage forms |
| gptkbp:stockExchange |
gptkb:Nasdaq_Riga
|
| gptkbp:website |
https://www.grindeks.eu/
|
| gptkbp:bfsParent |
gptkb:Richter_Gedeon_Plc
|
| gptkbp:bfsLayer |
7
|